Senior Scientist
Tarsus Pharmaceuticals
Senior Scientist
Tarsus Pharmaceuticals
Develops FDA-approved ophthalmic therapies
Hi Tarsan!
Thanks for your interest in this position. Please review the details and if role and if it's something that could match your career goals, connect with your current manager and HRBP to discuss if your experience and skills line up. If everything is a go, please apply and the Talent Acquisition team will contact you for an interview so we can also get to know you better.
- Your Human Resources Team
About the Role
The Sr. Scientist, Analytical Development is responsible for leading analytical activities supporting clinical-stage drug substance and drug product development programs. This role provides phase-appropriate analytical development, validation, and analytical CMC regulatory support to ensure successful advancement of development candidates through clinical and commercial milestones. The Sr. Scientist will lead analytical method development and validation activities, analytical risk assessments, and control strategy development for drug substance, drug product, excipients, impurities, degradation products, and critical quality attributes. The individual will serve as a key technical contributor and cross-functional partner while providing scientific oversight of external laboratories and development organizations.
Key Responsibilities
Factors for Success:
Tarsans are also expected to exemplify our core leadership competencies, including:
A Few Other Details Worth Mentioning:
At Tarsus, we understand the importance of attracting and retaining top talent. The expected base pay range for this position is $120,000 - $168,000 plus bonus, stock equity, and comprehensive benefits. The base pay range reflects the target range for this position, but individual pay will be determined by additional factors such as job-related skills, experience and relevant education or training. Our benefits include health, dental and vision insurance benefits to ensure your well-being. We believe in work-life balance and offer generous paid time off, including vacation, holidays, and personal days. For more details regarding Tarsus benefits, please visit: https://eb.alliant.com/26tarsusbenefitssnapshot.
#LI-Hybrid
Develops FDA-approved ophthalmic therapies
Tarsus Pharmaceuticals develops and markets treatments for eye care and infectious diseases, including XDEMVY (lotilaner ophthalmic solution 0.25%), an FDA-approved eye drop for Demodex Blepharitis. The product is applied as a medicated eye drop to kill Demodex mites and relieve eyelid inflammation. The company differentiates itself with a focused ocular/infectious-disease portfolio, an FDA-approved therapy, and active partnerships to expand its research and reach. Its goal is to address unmet medical needs, grow its product lineup through commercialization, and pursue new indications in eye care and infectious diseases.
Explore more opportunities at Tarsus Pharmaceuticals